Suppr超能文献

单纯膜性和增殖性狼疮性肾炎患者肾脏样本的蛋白质组学分析。

Proteomic profiling of kidney samples in patients with pure membranous and proliferative lupus nephritis.

作者信息

Chen Yun-Ying, Ding Ying, Li Lin-Lin, Han Sha-Sha, Huang Min, Wong Catherine Cl, Yu Feng, Zhao Ming-Hui

机构信息

Renal Division, Department of medicine, Peking University First Hospital; Institute of Nephrology, 12465Peking University, Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, PR, China.

Department of Nephrology, 594822Peking University International Hospital, Beijing, P.R. China.

出版信息

Lupus. 2022 Jun;31(7):837-847. doi: 10.1177/09612033221094711. Epub 2022 Apr 21.

Abstract

Renal injury in lupus nephritis (LN) does not manifest as one uniform entity. The clinical presentation, management, and prognosis of membranous LN (MLN) differ from that of the proliferative LN (PLN). Differentiating the molecular mechanisms involved in MLN and PLN and discovering the reliable biomarkers for early diagnosis and target therapy are important. We compared the kidney protein expression patterns of 11 pure MLN and 12 pure PLN patients on formalin-fixed paraffin-embedded (FFPE) kidney tissues using label-free liquid chromatography-mass spectrometry (LC-MS) for quantitative proteomics analysis. FunRich software was used to identify proteins in differentially expressed pathways. Quantitative comparisons of differentially expressed proteins in each patient were further analyzed based on protein intensity levels determined by LC-MS. The protein-protein interaction (PPI) network of the differentially expressed genes (DEGs) was established through Search Tool for the Retrieval of Interacting Genes database (STRING) website, visualized by Cytoscape. A total of 5112 proteins were identified. In total, 12 significantly upregulated (fold change ≥2, < 0.05) proteins were identified in the MLN group and 220 proteins (fold change ≥2, < 0.05) were upregulated in the PLN group. Further analysis showed that the most significant upregulated pathway involved in MLN was histone deacetylase (HDAC) class I pathway, and the three most significant upregulated pathways in PLN were interferon signaling, interferon gamma signaling, and the immune system. Next, we selected sirtuin-2 (SIRT2) in MLN, and vascular cell adhesion protein 1 (VCAM1) and Bcl-xl in PLN for further mass spectrometry (MS) intensity and PPI analysis. SIRT2 expression was significantly increased in the MLN group compared with the PLN group, and VCAM1, Bcl-xl expression was significantly increased in the PLN group compared with the MLN group, based on MS intensity. These results may help to improve our understanding of the underlying molecular mechanisms of MLN and PLN and provide potential targets for the diagnosis and treatment of different subclasses of LN.

摘要

狼疮性肾炎(LN)中的肾损伤并非表现为单一的统一形式。膜性LN(MLN)的临床表现、治疗及预后与增殖性LN(PLN)不同。区分MLN和PLN所涉及的分子机制并发现用于早期诊断和靶向治疗的可靠生物标志物很重要。我们使用无标记液相色谱 - 质谱(LC - MS)对11例纯MLN患者和12例纯PLN患者的福尔马林固定石蜡包埋(FFPE)肾组织进行肾脏蛋白质表达模式比较,以进行定量蛋白质组学分析。使用FunRich软件鉴定差异表达途径中的蛋白质。基于LC - MS测定的蛋白质强度水平,进一步分析每位患者中差异表达蛋白质的定量比较。通过搜索相互作用基因数据库(STRING)网站建立差异表达基因(DEG)的蛋白质 - 蛋白质相互作用(PPI)网络,并由Cytoscape进行可视化。共鉴定出5112种蛋白质。MLN组共鉴定出12种显著上调(倍数变化≥2,<0.05)的蛋白质,PLN组有220种蛋白质(倍数变化≥2,<0.05)上调。进一步分析表明,MLN中上调最显著的途径是I类组蛋白去乙酰化酶(HDAC)途径,PLN中上调最显著的三个途径是干扰素信号传导、干扰素γ信号传导和免疫系统。接下来,我们在MLN中选择沉默调节蛋白2(SIRT2),在PLN中选择血管细胞粘附蛋白1(VCAM1)和Bcl - xl进行进一步的质谱(MS)强度和PPI分析。基于MS强度,与PLN组相比,MLN组中SIRT2表达显著增加,与MLN组相比,PLN组中VCAM1、Bcl - xl表达显著增加。这些结果可能有助于增进我们对MLN和PLN潜在分子机制的理解,并为LN不同亚类的诊断和治疗提供潜在靶点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验